KPW
RYTM icon

Kore Private Wealth’s Rhythm Pharmaceuticals RYTM Stock Holding History

Kore Private Wealth’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$11K – 918
2020
Q2 		$11K Hold
500
– – ﹤0.01% 769
2020
Q1 		$8K Hold
500
– – ﹤0.01% 728
2019
Q4 		$11K Buy
+500
New +$11.1K ﹤0.01% 729
2019
Q2 		– Sell
-500
Closed -$14K – 673
2019
Q1 		$14K Hold
500
– – ﹤0.01% 559
2018
Q4 		$13K Buy
+500
New +$13.8K ﹤0.01% 543

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kore Private Wealth's RYTM Position: Q3 2020 in Review

Kore Private Wealth sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2020, closing a stake of 500 shares — an estimated $11K sold.

Kore Private Wealth first reported a position in RYTM in Q4 2018 and held it in 5 quarters. The position peaked at $14K in Q1 2019. 115 funds tracked by Wall St. Rank hold RYTM as of Q3 2020.

  • Kore Private Wealth reported no remaining Rhythm Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 500 Rhythm Pharmaceuticals shares in Q3 2020, an estimated $11K.
  • Kore Private Wealth first reported a position in Rhythm Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • Kore Private Wealth's Rhythm Pharmaceuticals position peaked at $14K in Q1 2019.
  • 115 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.